Skip to main content
Erschienen in: Inflammation Research 10/2020

13.07.2020 | Short Communication

Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis

verfasst von: Beth E. Rumberger, Erika L. Boarder, Sherry L. Owens, Michael D. Howell

Erschienen in: Inflammation Research | Ausgabe 10/2020

Einloggen, um Zugang zu erhalten

Abstract

Objective

Hidradenitis suppurativa (HS) is a chronic inflammatory disease with limited treatment options; therefore, the current study investigated the downstream signaling pathways that are differentially expressed in HS subjects and may drive disease pathogenesis.

Methods

The expression of 144 genes was evaluated in the skin of 16 healthy subjects and 34 subjects with mild to severe HS using QuantiGene Plex assay.

Results

One hundred and twenty-nine genes were significantly elevated in lesional HS skin as compared to the skin of healthy controls including pro-inflammatory cytokines (IL-1α, IL-6, TNF-α), IL-17-associated cytokines (IL-17A, IL-17F, IL-23A), the IL-10 family of cytokines (IL-10, IL-19, IL-20, IL-22, IL-24), and IFN family members (IFNA1, IFNB1, IFNG, IL-12B). This corresponded with increased expression of tyrosine kinases (JAK1, JAK3, BTK, SYK) and their downstream signaling partners (STAT1, STAT2, STAT3, STAT5A, STAT5B, STAT6).

Conclusion

These data illustrate the diverse immune activation in lesional HS skin and suggest that deeper interrogation of the disease heterogeneity may reveal unique opportunities for targeted therapies in designated subpopulations.
Literatur
1.
Zurück zum Zitat Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6:18.CrossRef Sabat R, Jemec GBE, Matusiak L, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020;6:18.CrossRef
2.
Zurück zum Zitat Hessam S, Sand M, Gambichler T, et al. Correlation of inflammatory serum markers with disease severity in subjects with hidradenitis suppurativa (HS). J Am Acad Dermatol. 2015;73:998–1005.CrossRef Hessam S, Sand M, Gambichler T, et al. Correlation of inflammatory serum markers with disease severity in subjects with hidradenitis suppurativa (HS). J Am Acad Dermatol. 2015;73:998–1005.CrossRef
3.
Zurück zum Zitat Matusiak L, Szczech J, Bieniek A, et al. Increased interleukin (IL)-17 serum levels in subjects with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents. J Am Acad Dermatol. 2017;76:670–5.CrossRef Matusiak L, Szczech J, Bieniek A, et al. Increased interleukin (IL)-17 serum levels in subjects with hidradenitis suppurativa: implications for treatment with anti-IL-17 agents. J Am Acad Dermatol. 2017;76:670–5.CrossRef
4.
Zurück zum Zitat Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375:422–34.CrossRef Kimball AB, Okun MM, Williams DA, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375:422–34.CrossRef
5.
Zurück zum Zitat Scheinfeld N, Sundaram M, Teixeira H, et al. Reduction in pain scores and improvement in depressive symptoms in subjects with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial. Dermatol Online J. 2016;22(3):2. Scheinfeld N, Sundaram M, Teixeira H, et al. Reduction in pain scores and improvement in depressive symptoms in subjects with hidradenitis suppurativa treated with adalimumab in a phase 2, randomized, placebo-controlled trial. Dermatol Online J. 2016;22(3):2.
6.
Zurück zum Zitat Moran B, Sweeney CM, Hughes R, et al. Hidradenitis suppurativa is characterised by dysregulation of the Th17: Treg cell axis which is corrected by anti-TNF therapy. J Invest Dermatol. 2017;137:2389–95.CrossRef Moran B, Sweeney CM, Hughes R, et al. Hidradenitis suppurativa is characterised by dysregulation of the Th17: Treg cell axis which is corrected by anti-TNF therapy. J Invest Dermatol. 2017;137:2389–95.CrossRef
7.
Zurück zum Zitat Hoffman LK, Tomalin LE, Schultz G, et al. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and plasma cell signature. PLoS ONE. 2018;13(9):e0203672.CrossRef Hoffman LK, Tomalin LE, Schultz G, et al. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and plasma cell signature. PLoS ONE. 2018;13(9):e0203672.CrossRef
8.
Zurück zum Zitat Shanmugam VK, Jones D, McNish S, et al. Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis. Clin Exp Derm. 2019;44:882–92.CrossRef Shanmugam VK, Jones D, McNish S, et al. Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis. Clin Exp Derm. 2019;44:882–92.CrossRef
9.
Zurück zum Zitat Zouboulis CC, Nogueira da Costa A, Makrantonaki E, et al. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34:846–61.CrossRef Zouboulis CC, Nogueira da Costa A, Makrantonaki E, et al. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020;34:846–61.CrossRef
10.
Zurück zum Zitat Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: current and emerging treatments. J Am Acad Dermatol. 2020;82:1061–82.CrossRef Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: current and emerging treatments. J Am Acad Dermatol. 2020;82:1061–82.CrossRef
Metadaten
Titel
Transcriptomic analysis of hidradenitis suppurativa skin suggests roles for multiple inflammatory pathways in disease pathogenesis
verfasst von
Beth E. Rumberger
Erika L. Boarder
Sherry L. Owens
Michael D. Howell
Publikationsdatum
13.07.2020
Verlag
Springer International Publishing
Erschienen in
Inflammation Research / Ausgabe 10/2020
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-020-01381-7

Weitere Artikel der Ausgabe 10/2020

Inflammation Research 10/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.